News & Events about Livanova Plc.
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO, an implantable pulse generator (IPG) with a dual-pin header to provide VNS Therapy for the treatment of drug-resistant epilepsy. The dual-pin header distinguishes this latest IPG...
Business Wire
2 months ago
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) 2022 Annual Meeting, taking place December 2-6 in Nashville, Tennessee. The Companys therapies and technologies will be featured in seven...
Business Wire
2 months ago
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal membrane oxygenation (ECMO) from the U.S. Food and Drug Administration (FDA) for LifeSPARC, the Companys next-generation Advanced Circulatory...
Business Wire
2 months ago
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its Chief Executive Officer Damien McDonald will present a general business update during fireside chats at three healthcare conferences in New York this month: Stifel Healthcare Conference 2022...
Shares of LivaNova PLC (NASDAQ:LIVN Get Rating) have received an average recommendation of Buy from the six research firms that are presently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among...